Nurix Therapeutics (NRIX) Ending Cash Balance (2019 - 2026)
Nurix Therapeutics (NRIX) reported Ending Cash Balance of $721.02 million for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 808.0% from $79.41 million a year earlier and up 950.2% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Ending Cash Balance (2019 - 2026) Analysis & Trends
For FY2025 (ended Nov 30, 2025), Nurix Therapeutics posted Ending Cash Balance of $247.93 million, up 123.6% from FY2024.
- Ending Cash Balance has a five-year compound annual growth rate of 15.7% (FY2020 to FY2025).
- By fiscal year, Ending Cash Balance came in at $110.9 million in FY2024 (+99.7%), $55.53 million in FY2023 (-15.1%), $65.38 million in FY2022 (-19.1%) and $80.79 million in FY2021 (-32.4%).
- The fiscal Q3 2026 figure ranks as the highest quarterly Ending Cash Balance in data going back to fiscal Q3 2019.
- Year over year, Ending Cash Balance gained in four of the last eight quarters, with growth averaging 126.1%.
- The high point for year-over-year Ending Cash Balance in five years was fiscal Q3 2026 (growth of 808.0%); the low point was fiscal Q2 2022 (a decline of 77.5%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $68.65 million (Q2 2026), $72.16 million (Q1 2026) and $247.93 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.89 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.88 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 1.03 Bn |
| 10 | Nurix Therapeutics | 2.77 Bn | 141.68 Mn | - | 721.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 721.02 Mn |
| May 31, 2026 | 68.65 Mn |
| Feb 28, 2026 | 72.16 Mn |
| Nov 30, 2025 | 247.93 Mn |
| Aug 31, 2025 | 79.41 Mn |
| May 31, 2025 | 85.16 Mn |
| Feb 28, 2025 | 76.82 Mn |
| Nov 30, 2024 | 110.90 Mn |
| Aug 31, 2024 | 99.95 Mn |
| May 31, 2024 | 117.69 Mn |
| Feb 29, 2024 | 50.71 Mn |
| Nov 30, 2023 | 55.53 Mn |
| Aug 31, 2023 | 43.21 Mn |
| May 31, 2023 | 59.86 Mn |
| Feb 28, 2023 | 34.47 Mn |
| Nov 30, 2022 | 65.38 Mn |
| Aug 31, 2022 | 48.46 Mn |
| May 31, 2022 | 42.43 Mn |
| Feb 28, 2022 | 79.68 Mn |
| Nov 30, 2021 | 80.79 Mn |
API Access
Nurix Therapeutics Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();